ArticleRedox biology2024

Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress.

Weijuan Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.